Sripal Bangalore MD MHA, FACC, FAHA, FSCAI
Interventional Cardiology
Professor of Medicine, Director of Invasive and Interventional Cardiology, Director of Complex Coronary Intervention, Interventional Director, Adult ECMO, PERT and MCS Program, Bellevue Hospital Center, Director of Research for the Cardiac Catheterization Laboratory
Join to View Full Profile
NYU Langone Health 530 First AvenueSKI 9R109New York, NY 10016
Phone+1 212-263-3540
Fax+1 212-263-3988
Dr. Bangalore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sripal Bangalore is a cardiologist in New York, NY. He specializes in interventional cardiology and preventive cardiology and is experienced in hypertension, coronary artery disease, preventive cardiology, cardiac critical care, and coronary restenosis. Dr. Bangalore's expertise is in complex coronary intervention including chronic total occlusion, zero contrast PCI for those with advanced CKD, advanced mechanical circulatory support device including ECMO and in percutaneous extraction of right sided masses/thrombus and pulmonary emboli.
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, 2009 - 2010- Brigham and Women's HospitalFellowship, Interventional Cardiology, 2008 - 2010
Icahn School of Medicine at Mount Sinai/Morningside/BronxCareFellowship, Cardiovascular Disease, 2005 - 2008- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2003 - 2005
- Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2002 - 2003
Bangalore Medical CollegeClass of 2000
Certifications & Licensure
NY State Medical License 2010 - 2025
MA State Medical License 2008 - 2010
OH State Medical License 2008 - 2009
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
CBNCNuclear Cardiology
Clinical Trials
- BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Start of enrollment: 2020 Sep 08
Publications & Presentations
PubMed
- Management and outcomes of patients with ST-elevation myocardial infarction and liver disease-Insights from the Nationwide Readmissions Database.Manoj Kumar, Nso Nso, Yehya Khlidj, Shafaqat Ali, Nomesh Kumar
American Heart Journal Plus. 2025-04-01 - Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease.Arushi Singh, Robert S Zhang, Sripal Bangalore
Heart Failure Clinics. 2025-04-01 - 1 citationsGuideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.David J Maron, Jonathan D Newman, Rebecca Anthopolos, Ying Lu, Susanna Stevens
Journal of the American College of Cardiology. 2025-04-01
Press Mentions
ISCHEMIA: No Clinical Event Reduction with Invasive Strategy in CTO PatientsMarch 26th, 2025- 90% of Adults in the U.S. At Risk of Heart Disease. What to Know About Metabolic SyndromeMay 8th, 2024
- Weight Fluctuation a Normal Daily Occurrence, but Long-Term Ups and Downs Can Be HarmfulDecember 3rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
